In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

There have been two really troubling stories over the past week involving the Government’s welfare gimmicks. First up, health secretary Wes Streeting this week announced a new collaboration with Lilly ...

A group of health professionals have called for a review of obesity management services in light of increased public demand ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...

A major trial is coming to Greater Manchester to see how a new drug can tackle obesity. The ‘five-year real-world evidence study’ will be run by Health Innovation Manchester and pharmaceutical giant ...